摘要
Introduction/Background: Persistent microglial activation contributes to secondary brain injury and incomplete functional recovery after ischemic stroke. However, the temporal dynamics and functional significance of microglial ISG15 following stroke remain unclear.
Methods: Mice underwent transient middle cerebral artery occlusion (tMCAO), with brain tissues examined at 1, 3, 7, 14, and 28 days. Immunoblotting, immunofluorescence, transcriptomic profiling of flow-sorted microglia, single-cell RNA sequencing, and spatial transcriptomics were used to characterize Isg15 transcription, ISG15 protein expression, and ISGylation-related changes. Microglia-specific Isg15 conditional knockout (cKO) mice and primary microglia subjected to oxygen-glucose deprivation/reoxygenation were used to assess inflammation, microglial morphology, brain injury, and neurological outcomes.
Results: Free ISG15 and ISG15-conjugated proteins increased after tMCAO, peaked at day 7, and remained elevated at day 28. Isg15 transcripts and ISG15 protein were enriched in microglia, particularly within ischemic regions, accompanied by increased expression of ISGylation-related genes. Isg15 deletion reduced oxygen-glucose deprivation/reoxygenation-induced IL-1β, IL-6, and TNF-α secretion and attenuated microglial morphological activation in the cortex and striatum. Following tMCAO, cKO mice showed fewer foot faults, improved rotarod performance and grip strength, faster adhesive removal, and lower neurological severity scores. They also demonstrated improved spatial learning and memory in the Morris water maze without significant differences in swimming speed. Histological analyses revealed smaller infarcts at day 7 and reduced brain tissue loss at day 28.
Conclusion: Ischemic stroke induces sustained upregulation of microglial ISG15 and its conjugation system. Microglial Isg15 deletion attenuates neuroinflammation and brain injury while improving long-term neurological recovery, identifying ISG15 as a potential therapeutic target.
